YaLin Zeng

Mr. YaLin Zeng

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
Q轻QQ情侣 轻轻巧巧 轻轻巧巧
QQ情侣 轻轻巧巧 轻轻巧巧
FYFen Yang
Fen Yang
DYDongliang Yan
Dongliang Yan
YZYaLin Zeng
YaLin Zeng
BWBenzheng Wei
Benzheng Wei
WHWeikai He
Weikai He
β-amyloid cleaving enzyme 1 (BACE1) is regarded as an important target of drug design toward the treatment of Alzheimer’s disease (AD). In this study, three separate molecular dynamics (MD) simulations and calculations of binding free energies were carried out to comparatively determine the identification mechanism of BACE1 for three inhibitors, 60W, 954 and 60X. The analyses of MD trajectories indicated that the presence of three inhibitors influences the structural stability, flexibility and internal dynamics of BACE1. Binding free energies calculated by using solvated interaction energy (SIE) and molecular mechanics generalized Born surface area (MM-GBSA) methods reveal that the hydrophobic interactions provide decisive forces for inhibitor–BACE1 binding. The calculations of residue-based free energy decomposition suggest that the sidechains of residues L91, D93, S96, V130, Q134, W137, F169 and I179 play key roles in inhibitor–BACE1 binding, which provides a direction for future drug design toward the treatment of AD.